HepG2 cells acquire stem cell-like characteristics after immune cell stimulation
- 577 Downloads
The presence of cancer stem cells (CSCs) is currently regarded as one of the main culprits of tumor formation and therapy failure. It is known that chronic inflammation is associated with CSCs, but it is not clear yet how inflammation affects the development of CSCs. In the present study we aimed to examine the relationship between cancer cell stimulation mediated by immune cells and the acquisition of a CSC-like phenotype.
Cancer cells derived from single hepatocarcinoma HepG2 cells were treated with mouse splenic B cells (MSBCs) and mouse peritoneal macrophage cells (MPMCs), respectively. The stem cell-like characteristics of the resulting HepG2 cells (MSBC-HepG2 and MPMC-HepG2) were evaluated using different assays, including biomarker assays, in vitro tumoroid and colony forming assays, in vivo tumor forming assays and signal transduction pathway activation assays.
Various stemness characteristics of HepG2 cells, including self-renewal, proliferation, chemoresistance and tumorigenicity were evaluated. The expression levels of stemness-related genes and its encoded proteins in the MSBC-HepG2 and MPMC-HepG2 cells were assessed using RT-PCR and FACS analyses. We found that MSBC-HepG2 and MPMC-HepG2 cells possess hepatic CSC properties, including persistent self-renewal, extensive proliferation, drug resistance, high tumorigenic capacity and over-expression of CSC-related genes and proteins (i.e., EpCAM, ALDH, CD133 and CD44), compared to the parental cells. We also found that 1x103 MSBC-HepG2 and MPMC-HepG2 cells were able to form tumors in NOD/SCID mice and that the Notch and SHH signaling pathways were highly activated in MSBC-HepG2 cells.
We conclude that the immune system may have a double-edge effect on cancer development. On one hand, immune cells such as B lymphocytes and macrophages may recognize, attack and eliminate cancer cells, whereas on the other hand, they may promote a subset of cancer cells to acquire stem cell-like characteristics.
KeywordsCancer stem cells HepG2 cells Splenic B cells Peritoneal macrophage cells
This study was supported by the Fujian Minfaigaoji foundation (NO. 2014–514), the Fujian Education Office (NO. JA12033) and the Fuzhou University (NO.2013-XQ-27), Fujian province, P.R. China.
Compliance with ethical standards
The authors have declared that no competing interests exist.
- 21.M. Hensel, A. Schneeweiss, H.P. Sinn, G. Egerer, M. Kornacker, E. Solomayer, R. Haas, G. Bastert, A.D. Ho, Stem cell dose and tumorbiologic parameters as prognostic markers for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous blood stem cell support. Stem Cells 20, 32–40 (2002)CrossRefPubMedGoogle Scholar
- 22.E.D. Hsi, S.H. Jung, R. Lai, J.L. Johnson, J.R. Cook, D. Jones, S. Devos, B.D. Cheson, L.E. Damon, J. Said, Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a cancer and leukemia group B 59909 correlative science study. Leuk. Lymphoma 49, 2081–2090 (2008)PubMedCentralCrossRefPubMedGoogle Scholar
- 23.H. Ohata, T. Ishiguro, Y. Aihara, A. Sato, H. Sakai, S. Sekine, H. Taniguchi, T. Akasu, S. Fujita, H. Nakagama, K. Okamoto, Induction of the stem-like cell regulator CD44 by Rho kinase inhibition contributes to the maintenance of colon cancer-initiating cells. Cancer Res. 72, 5101–5110 (2012)CrossRefPubMedGoogle Scholar
- 29.F. Jin, H.S. Li, L. Zhao, Y.J. Wei, H. Zhang, Y.J. Guo, R. Pang, X.B. Jiang, H.Y. Zhao, Expression of anti-apoptotic and multi-drug resistance-associated protein genes in cancer stem cell isolated from TJ905 glioblastoma multiforme cell line. Zhonghua Yi Xue Za Zhi 88, 2312–2316 (2008)PubMedGoogle Scholar
- 30.H. Yi, H.J. Cho, S.M. Cho, K. Jo, J.A. Park, S.H. Lee, B.J. Chang, J.S. Kim, H.C. Shin, Effect of 5-FU and MTX on the expression of drug-resistance related cancer stem cell markers in non-small cell lung cancer cells. Korean J Physiol Pharmacol 16, 11–16 (2012)PubMedCentralCrossRefPubMedGoogle Scholar
- 31.E.H. Huang, M.J. Hynes, T. Zhang, C. Ginestier, G. Dontu, H. Appelman, J.Z. Fields, M.S. Wicha, B.M. Boman, Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 69, 3382–3389 (2009)PubMedCentralCrossRefPubMedGoogle Scholar
- 34.K.A. Hassan, L. Wang, H. Korkaya, G. Chen, I. Maillard, D.G. Beer, G.P. Kalemkerian, M.S. Wicha, Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma. Clin. Cancer Res. 19, 1972–1980 (2013)PubMedCentralCrossRefPubMedGoogle Scholar
- 40.M. de Magalhaes-Silverman, L. Hammert, B. Lembersky, J. Lister, W. Rybka, E. Ball, High-dose chemotherapy and autologous stem cell support followed by post-transplant doxorubicin and taxol as initial therapy for metastatic breast cancer: hematopoietic tolerance and efficacy. Bone Marrow Transplant. 21, 1207–1211 (1998)CrossRefGoogle Scholar
- 44.J.Y. Wong, G. Somlo, T. Odom-Maryon, L.E. Williams, A. Liu, D. Yamauchi, A.M. Wu, P. Yazaki, S. Wilczynski, J.E. Shively, S. Forman, J.H. Doroshow, A.A. Raubitschek, Initial clinical experience evaluating Yttrium-90-chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancer. Clin. Cancer Res. 5, 3224s–3231s (1999)PubMedGoogle Scholar
- 47.Y. Liu, Z.P. Han, S.S. Zhang, Y.Y. Jing, X.X. Bu, C.Y. Wang, K. Sun, G.C. Jiang, X. Zhao, R. Li, L. Gao, Q.D. Zhao, M.C. Wu, L.X. Wei, Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer. J. Biol. Chem. 286, 25007–25015 (2011)PubMedCentralCrossRefPubMedGoogle Scholar
- 49.T.S. Zhu, M.A. Costello, C.E. Talsma, C.G. Flack, J.G. Crowley, L.L. Hamm, X. He, S.L. Hervey-Jumper, J.A. Heth, K.M. Muraszko, F. DiMeco, A.L. Vescovi, X. Fan, Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells. Cancer Res. 71, 6061–6072 (2011)PubMedCentralCrossRefPubMedGoogle Scholar